中文名 | 4-(1,2,4-噁二唑-3-基)苯胺 |
---|---|
英文名 | 4-(1,2,4-oxadiazol-3-yl)aniline |
英文别名 |
Benzenamine,4-(1,2,4-oxadiazol-3-yl)
3-(4-Aminophenyl)-1,2,4-oxadiazol 4-([1,2,4]Oxadiazol-3-yl)phenylamine 3-(4-aminophenyl)-1,24-oxadiazole 4]oxadiazol-3-yl-phenylamine |
分子式 | C8H7N3O |
---|---|
分子量 | 161.16100 |
精确质量 | 161.05900 |
PSA | 64.94000 |
LogP | 1.90000 |
储存条件 | 2-8℃,避光,干燥,密封 |
危害码 (欧洲) | Xi |
---|
~92% 59908-70-2 |
文献:Forest Laboratories Holdings Limited Patent: US2009/239810 A1, 2009 ; Location in patent: Page/Page column 54 ; US 20090239810 A1 |
~% 59908-70-2 |
文献:Haugwitz, R. D.; Martinez, A. J.; Venslavsky, J.; Angel, R. G.; Maurer, B. V.; et al. Journal of Medicinal Chemistry, 1985 , vol. 28, # 9 p. 1234 - 1241 |
~% 59908-70-2 |
文献:AGIOS PHARMACEUTICALS, INC.; POPOVICI-MULLER, Janeta; SALITURO, Francesco, G.; SAUNDERS, Jeffrey, O.; TRAVINS, Jeremey; YAN, Shunqi Patent: WO2012/9678 A1, 2012 ; WO 2012/009678 A1 |
~% 59908-70-2 |
文献:AGIOS PHARMACEUTICALS, INC.; POPOVICI-MULLER, Janeta; SALITURO, Francesco, G.; SAUNDERS, Jeffrey, O.; TRAVINS, Jeremey; YAN, Shunqi Patent: WO2012/9678 A1, 2012 ; WO 2012/009678 A1 |